A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181])

Condition:   Congenital Adrenal Hyperplasia Intervention:   Other: Pre-Screening Sponsor:   Adrenas Therapeutics Inc Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials